iguratimod has been researched along with ciclesonide in 1 studies
Studies (iguratimod) | Trials (iguratimod) | Recent Studies (post-2010) (iguratimod) | Studies (ciclesonide) | Trials (ciclesonide) | Recent Studies (post-2010) (ciclesonide) |
---|---|---|---|---|---|
134 | 19 | 109 | 284 | 108 | 100 |
Protein | Taxonomy | iguratimod (IC50) | ciclesonide (IC50) |
---|---|---|---|
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 4.33 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aoyagi, T; Baba, H; Kanamori, H; Niitsuma-Sugaya, I; Oshima, K; Sato, Y; Seike, I; Takei, K; Tokuda, K | 1 |
1 other study(ies) available for iguratimod and ciclesonide
Article | Year |
---|---|
Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Betacoronavirus; Chromones; Coronavirus Infections; COVID-19; Female; Humans; Pandemics; Pneumonia, Viral; Pregnenediones; Real-Time Polymerase Chain Reaction; RNA, Viral; SARS-CoV-2; Sulfonamides; Thorax; Virus Shedding | 2020 |